SXTC
China SXT Pharmaceuticals·NASDAQ
--
--(--)
--
--(--)
SXTC Filings
Filing Date
Form Description
Form Type
2026-01-13
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Key Events
2026-01-13 · Key Events
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2026-01-12
Form 424B5 - Prospectus [Rule 424(b)(5)]
2026-01-12 ·
Form 424B5 - Prospectus [Rule 424(b)(5)]
2025-12-31
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Financials
2025-12-31 · Financials
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2025-11-17
Form EFFECT - Notice of Effectiveness
2025-11-17 ·
Form EFFECT - Notice of Effectiveness
2025-11-10
Form F-3 - Registration statement by foreign private issuers
2025-11-10 ·
Form F-3 - Registration statement by foreign private issuers
2025-11-10
Form POS AM - Post-Effective amendments for registration statement
2025-11-10 ·
Form POS AM - Post-Effective amendments for registration statement
2025-08-07
Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2025-08-07 ·
Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2025-08-07
Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2025-08-07 ·
Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2025-08-07
Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2025-08-07 ·
Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2025-08-07
Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2025-08-07 ·
Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
